Concurrent acquired BRAF V600E mutation and MET...

  • Main
  • 2018 / 3
  • Concurrent acquired BRAF V600E mutation and MET...

Concurrent acquired BRAF V600E mutation and MET amplification as resistance mechanism of first-line osimertinib treatment in NSCLC EGFR -mutated patient

Minari, Roberta, Bordi, Paola, La Monica, Silvia, Squadrilli, Anna, Leonetti, Alessandro, Bottarelli, Lorena, Azzoni, Cinzia, Lagrasta, Constanza Anna Maria, Gnetti, Lelizia, Campanini, Nicoletta, Pet
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Language:
english
Journal:
Journal of Thoracic Oncology
DOI:
10.1016/j.jtho.2018.03.013
Date:
March, 2018
File:
PDF, 1.20 MB
english, 2018
Conversion to is in progress
Conversion to is failed